首页> 外国专利> Use of fibrin sealant to maintain hemostasis, lymphostasis and prevent local accumulation of body fluids

Use of fibrin sealant to maintain hemostasis, lymphostasis and prevent local accumulation of body fluids

机译:使用纤维蛋白封闭剂维持止血,淋巴稳定和防止体液局部积聚

摘要

Fibrin sealant, comprised of thrombin and fibrinogen which are mixed together and polymerized autocatalytically, is used to maintain hemostasis, lymphostasis or prevent local fluid accumulation in situations where bleeding or fluid accumulation may retard recovery, induce or aggravate pain and discomfort, or present a health risk. Fibrin sealant is employed in wound closure where a skin flap is secured to a wound perimeter, as in mastectomies, to incisions made surgically or endoscopically, in orthopedic surgery where bleeding is profuse, and in solid organ biopsies. Fibrin sealant is also effective in suppressing regrowth of surgically excised tumors. Fibrin sealant applied to the area surrounding an opening in a blood or lymphatic vessel due to catheterization is also effective in maintaining hemostasis.
机译:纤维蛋白封闭剂由凝血酶和纤维蛋白原混合在一起并自动催化聚合而成,可用于维持止血,淋巴稳定或防止局部积液,以防出血或积液可能阻碍恢复,诱发或加重疼痛和不适或对健康有益风险。纤维蛋白封闭剂用于伤口闭合处,如在乳房切除术中,将皮瓣固定在伤口周围,在外科手术或内窥镜下进行的切口,在整形外科手术中,其中大量出血,以及在实体器官活检中。纤维蛋白封闭剂也有效地抑制了手术切除的肿瘤的再生。由于导管插入术而施加到围绕血液或淋巴管的开口周围的区域的纤维蛋白密封剂在保持止血方面也是有效的。

著录项

  • 公开/公告号AU9786198A

    专利类型

  • 公开/公告日1999-05-03

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF VIRGINIA;

    申请/专利号AU19980097861

  • 发明设计人 WILLIAM D. SPOTNITZ;

    申请日1998-10-09

  • 分类号A61K9/00;

  • 国家 AU

  • 入库时间 2022-08-22 02:22:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号